Your browser doesn't support javascript.
loading
Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis.
Chen, Han; Li, Xin-Zhu; Chen, Jia-Qing; Ren, Tian-Shu; Zhang, Ying-Shi; Wang, Yi-Nuo; Zhao, Qing-Chun.
Afiliação
  • Chen H; Department of Pharmacy, General Hospital of Northern Theater Command, Shenyang, People's Republic of China.
  • Li XZ; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
  • Chen JQ; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
  • Ren TS; Department of Pharmacy, General Hospital of Northern Theater Command, Shenyang, People's Republic of China.
  • Zhang YS; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
  • Wang YN; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
  • Zhao QC; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
Medicine (Baltimore) ; 102(27): e34122, 2023 Jul 07.
Article em En | MEDLINE | ID: mdl-37417602

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Hipoglicemiantes Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 / Hipoglicemiantes Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2023 Tipo de documento: Article